Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
This image was generated by AI and may not depict real events.
Stanford scientists have discovered a naturally occurring molecule called BRP that can mimic some of the effects of semaglutide, a widely used weight loss drug. BRP has shown promising results in animal studies, reducing food intake and body weight without common side effects.
Stanford Medicine researchers have identified a molecule that mimics some effects of semaglutide. This molecule, called BRP, targets the hypothalamus to reduce appetite. An AI tool called Peptide Predictor helped discover BRP by scanning human peptides. Animal tests showed BRP cut food intake by 50% and reduced fat. BRP may offer a more targeted approach to weight loss, avoiding common side effects. The discovery could reshape the future of weight loss treatments.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.